erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Tempera G et al. In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy. 2010 Jul-Sep Int J Immunopathol Pharmacol pmid:20943054
Pal N et al. Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India. 2010 Jul-Sep J Postgrad Med pmid:20739762
Darling EK and McDonald H A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum. 2010 Jul-Aug J Midwifery Womens Health pmid:20630358
Smith G Differential diagnosis of red eye. 2010 Jul-Aug Pediatr Nurs pmid:20860262
Dorobăţ OM et al. [Antibiotic resistance of Gram-positive cocci isolated in 2008]. 2010 Apr-Jun Bacteriol Virusol Parazitol Epidemiol pmid:21553473
Pană M et al. [Study of Streptococcus pneumoniae strains resistant to antibiotics analyzed at "Cantacuzino" NIRDMI during 2006-2008]. 2010 Apr-Jun Bacteriol Virusol Parazitol Epidemiol pmid:21553474
Nica M et al. [Bacterial strains isolated from systemic infections and reported for evaluation and antibiotic resistance surveillance by the "Dr. Victor BabeÅŸ" Clinical Hospital for Infectious and Tropical Diseases, Bucharest]. 2010 Apr-Jun Bacteriol Virusol Parazitol Epidemiol pmid:21553481
Namikawa H et al. Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. 2010 Arch. Dermatol. Res. pmid:19578864
Dhamdhere G et al. Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics. 2010 Antimicrob. Agents Chemother. pmid:20876376
He ZY et al. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. 2010 Respiration pmid:20881376
Liu Y et al. 9-Dihydroerythromycin ethers as motilin agonists--developing structure-activity relationships for potency and safety. 2010 Bioorg. Med. Chem. pmid:20869254
Leszczyńska K et al. Modulation of exogenous antibiotic activity by host cathelicidin LL-37. 2010 APMIS pmid:20955455
Atkins JL et al. Enhancement of antimicrobial activity by synthetic ion channel synergy. 2010 Chem. Commun. (Camb.) pmid:20931142
van der Beek MT et al. Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli. 2010 Clin. Microbiol. Infect. pmid:19438640
Aguilera R C et al. [Antimicrobial susceptibility, capsular serotypes and clonal relationship of invasive streptococcus pneumoniae isolates in adult population of the Bio-Bio region, Chile. 2005-2006]. 2010 Rev Chilena Infectol pmid:21186502
Pazoki-Toroudi H et al. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. 2010 J Dermatolog Treat pmid:20394495
Stringer E et al. Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. 2010 S. Afr. Med. J. pmid:20429491
Chandra B et al. Catalytic asymmetric synthesis of complex polypropionates: Lewis base catalyzed aldol equivalents in the synthesis of erythronolide B. 2010 Angew. Chem. Int. Ed. Engl. pmid:20209542
Yao J et al. Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers. 2010 Bioorg. Med. Chem. Lett. pmid:19959361
Tokuda A et al. Effects of macrolides on antigen-induced increases in cough reflex sensitivity in guinea pigs. 2010 Pulm Pharmacol Ther pmid:19835975
Padilla E et al. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. 2010 Antimicrob. Agents Chemother. pmid:19858254
Glass SK et al. Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006). 2010 J. Antimicrob. Chemother. pmid:19864333
Goetting-Minesky MP and Fenno JC A simplified erythromycin resistance cassette for Treponema denticola mutagenesis. 2010 J. Microbiol. Methods pmid:20691222
Mazzoncini JP et al. Human metapneumovirus: an emerging respiratory pathogen. 2010 J Emerg Med pmid:18584996
Banche G et al. Synergistic effect of erythromycin on polymorphonuclear cell antibacterial activity against erythromycin-resistant phenotypes of Streptococcus pyogenes. 2010 Int. J. Antimicrob. Agents pmid:20692129
Shi HY et al. Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism. 2010 Eur. J. Clin. Pharmacol. pmid:20669013
Bourne CR et al. Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1. 2010 Antimicrob. Agents Chemother. pmid:20606069
Bohnert JA et al. Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. 2010 Antimicrob. Agents Chemother. pmid:20606071
Horner P Chlamydia (uncomplicated, genital). 2010 BMJ Clin Evid pmid:21718568
Ren W et al. Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis. 2010 Inflamm. Res. pmid:20607583
Ortiz-Pérez A et al. High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species. 2010 Microb. Drug Resist. pmid:20624090
Dundar D et al. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients. 2010 Microb. Drug Resist. pmid:20624096
Zhang H et al. Investigating the role of native propionyl-CoA and methylmalonyl-CoA metabolism on heterologous polyketide production in Escherichia coli. 2010 Biotechnol. Bioeng. pmid:19806677
Harris JB et al. Cholera's western front. 2010 Lancet pmid:21112083
Kwatra D et al. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance. 2010 Int J Pharm pmid:20573570
Ying L and Tang D Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics. 2010 Curr Top Med Chem pmid:20536419
Fernandes NF et al. Pityriasis lichenoides et varioliformis acuta: a disease spectrum. 2010 Int. J. Dermatol. pmid:20465660
El-Mahdy TS et al. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. 2010 Anaerobe pmid:20541615
Kana BD et al. Depletion of resuscitation-promoting factors has limited impact on the drug susceptibility of Mycobacterium tuberculosis. 2010 J. Antimicrob. Chemother. pmid:20542905
Kadlec K and Schwarz S Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain. 2010 Antimicrob. Agents Chemother. pmid:20498309
Levêque D et al. [Mechanisms of pharmacokinetic drug-drug interactions]. 2010 Rev Med Interne pmid:19740579
Woosley LN et al. CEM-101 activity against Gram-positive organisms. 2010 Antimicrob. Agents Chemother. pmid:20176910
Mulhbacher J et al. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. 2010 PLoS Pathog. pmid:20421948
Morrow BJ et al. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone. 2010 Antimicrob. Agents Chemother. pmid:20176911
Fraser RJ and Bryant L Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient. 2010 Nutr Clin Pract pmid:20130155
Cocco G and Gasparyan AY Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis. 2010 Open Cardiovasc Med J pmid:20360980
Auerbach T et al. The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20080686
Krenauer A et al. EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression--a case report. 2010 Diagn Pathol pmid:20356360
Cousens S et al. Antibiotics for pre-term pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection. 2010 Int J Epidemiol pmid:20348116
Di Luca MC et al. Lysogenic transfer of mef(A) and tet(O) genes carried by Phim46.1 among group A streptococci. 2010 Antimicrob. Agents Chemother. pmid:20643900